Profil
Rachael Brake is currently the Director at M51 Topco, Inc. She previously worked as the Head-US Medical Affairs Oncology at Millennium Pharmaceuticals, Inc. from 2014 to 2021.
She then served as the Chief Scientific Officer at Corbus Pharmaceuticals Holdings, Inc. from 2021 to 2024.
Dr. Brake holds an undergraduate degree from The Australian National University and a doctorate degree from The University of Western Australia.
Aktive Positionen von Rachael Brake
| Unternehmen | Position | Beginn |
|---|---|---|
M51 Topco, Inc.
M51 Topco, Inc. Packaged SoftwareTechnology Services Develops medicine software that connect healthcare and life sciences | Direktor/Vorstandsmitglied | 27.06.2023 |
Ehemalige bekannte Positionen von Rachael Brake
| Unternehmen | Position | Ende |
|---|---|---|
| CORBUS PHARMACEUTICALS HOLDINGS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 19.02.2024 |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Corporate Officer/Principal | 01.01.2021 |
Ausbildung von Rachael Brake
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Australian National University
Australian National University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Western Australia
The University of Western Australia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Corbus Pharmaceuticals Holdings, Inc.
Corbus Pharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases | Health Technology |
M51 Topco, Inc.
M51 Topco, Inc. Packaged SoftwareTechnology Services Develops medicine software that connect healthcare and life sciences | Technology Services |
















